Related Experiment Video
Updated: Jul 20, 2025

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
Published on: April 8, 2016
Single-cell transcriptomics reveals prominent expression of IL-14, IL-18, and IL-32 in psoriasis
Bennet Frost1, Maria Schmidt2, Benjamin Klein1
1Department of Dermatology, Venereology and Allergology, University of Leipzig Medical Center, Leipzig, Germany.
This study reveals key immune cell types and inflammatory mediators in psoriasis. Interleukin-14 (TXLNA), IL-18, and IL-32 are significantly elevated in psoriatic skin, highlighting their role in disease pathogenesis.
Area of Science:
- Immunology
- Dermatology
- Genomics
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Cytokines and chemokines play a role in its pathogenesis.
Purpose of the Study:
- To characterize immune and non-immune cell populations in psoriasis.
- To identify inflammatory mediators involved in the disease using single-cell transcriptomics.
Main Methods:
- Single-cell transcriptomic analysis of psoriasis skin lesions from eight patients.
- Validation through in situ hybridization, serum analysis, and in vitro cell culture.
- Comparison with healthy control skin and a murine psoriasis model.
Main Results:
- Identified immune-activated cell types including keratinocytes, T-helper cells, dendritic cells, macrophages, and fibroblasts.
- Found prominent expression of Interleukin-14 (TXLNA), IL-18, and IL-32 in specific cell types within psoriatic lesions.
- Observed significantly higher percentages of IL-14, IL-18, and IL-32 expressing cells in psoriatic skin compared to healthy skin.
Conclusions:
- Provided a detailed view of psoriasis immune cell phenotypes.
- Supported the involvement of IL-14, IL-18, and IL-32 in the pathogenesis of psoriasis.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024